Genmab A/S (GNMSF) Net Shares Issued and Repurchased (2023 - 2026)

Genmab A (GNMSF) has 4 years of Net Shares Issued and Repurchased data on file, last reported at -$96.0 million in Q1 2026.

• Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to -$96.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 billion (changed N/A YoY) and the FY2024 annual result came in at -$560.0 million, down 591.36% from the prior year.
• Net Shares Issued and Repurchased rose to -$96.0 million in Q1 2026, from -$430.0 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of -$79.0 million in Q1 2024 to a low of -$560.0 million in Q3 2024.
• A 4-year average of -$341.1 million and a median of -$418.0 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Shares Issued and Repurchased tumbled 591.36% — and 2025, when it gained 23.21%.
• Tracing GNMSF's Net Shares Issued and Repurchased over 4 years: stood at -$81.0 million in 2023, then plunged by 591.36% to -$560.0 million in 2024, then increased by 23.21% to -$430.0 million in 2025, then surged by 77.67% to -$96.0 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at -$96.0 million (Q1 2026), -$430.0 million (Q3 2025), and -$406.0 million (Q2 2025), per Business Quant data.